Correlation Between IShares 20 and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares 20 and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares 20 and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IShares 20 Year and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on IShares 20 and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares 20 with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares 20 and Arrowhead Pharmaceuticals.

Diversification Opportunities for IShares 20 and Arrowhead Pharmaceuticals

  Correlation Coefficient

Very weak diversification

The 3 months correlation between IShares and Arrowhead is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding IShares 20 Year and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and IShares 20 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IShares 20 Year are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of IShares 20 i.e., IShares 20 and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares 20 and Arrowhead Pharmaceuticals

Considering the 90-day investment horizon IShares 20 Year is expected to generate 0.27 times more return on investment than Arrowhead Pharmaceuticals. However, IShares 20 Year is 3.7 times less risky than Arrowhead Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  9,677  in IShares 20 Year on September 2, 2022 and sell it today you would earn a total of  722.00  from holding IShares 20 Year or generate 7.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
ValuesDaily Returns

IShares 20 Year  vs.  Arrowhead Pharmaceuticals

 Performance (%) 
IShares 20 Year 
IShares Performance
0 of 100
Over the last 90 days IShares 20 Year has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, IShares 20 is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

IShares Price Channel

Arrowhead Pharmaceuticals 
Arrowhead Performance
0 of 100
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2023. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Arrowhead Price Channel

IShares 20 and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   

Pair Trading with IShares 20 and Arrowhead Pharmaceuticals

The main advantage of trading using opposite IShares 20 and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares 20 position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
IShares 20 vs. Quadratic Deflation ETF
IShares 20 vs. Microsoft
The idea behind IShares 20 Year and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Arrowhead Pharmaceuticals vs. Microsoft
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios